Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Special Issue, Part II</i> 20th International Symposium on Bioinformatics Research and Applications (ISBRA 2024).

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

<i>Special Issue, Part I</i> 20th International Symposium on Bioinformatics Research and Applications (ISBRA 2024).

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

Integrating Time and Frequency Domain Features of fMRI Time Series for Alzheimer's Disease Classification Using Graph Neural Networks.

Interdisciplinary sciences, computational life sciences·2025
Same author

Supervised graph contrastive learning for cancer subtype identification through multi-omics data integration.

Health information science and systems·2024
Same author

MHCLMDA: multihypergraph contrastive learning for miRNA-disease association prediction.

Briefings in bioinformatics·2024
Same author

Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.

Bioinformatics (Oxford, England)·2022

Related Experiment Video

Updated: Aug 11, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

MiRNA-gene network embedding for predicting cancer driver genes.

Wei Peng1,2, Rong Wu1, Wei Dai1,2

  • 1Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming, Yunnan 650500, PR  China.

Briefings in Functional Genomics
|February 8, 2023
PubMed
Summary

This study introduces GM-GCN, a novel graph convolution network approach for identifying cancer driver genes using gene-microRNA networks. GM-GCN improves cancer driver gene prediction accuracy compared to existing methods.

Keywords:
cancer driver genesgene–miRNA networkgraph convolutional neural networkmiRNA

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Related Experiment Videos

Last Updated: Aug 11, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.5K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Cancer development is driven by mutations in specific genes.
  • Accurate identification of cancer driver genes is crucial for targeted therapies and drug design.
  • Existing computational methods often overlook the regulatory role of microRNAs (miRNAs) in gene expression and disease.

Purpose of the Study:

  • To develop a novel computational approach, GM-GCN, for identifying cancer driver genes.
  • To leverage gene-miRNA interaction networks for improved driver gene prediction.
  • To integrate miRNA regulatory information into cancer driver gene identification.

Main Methods:

  • Construction of a comprehensive gene-miRNA network incorporating regulatory relationships.
  • Application of a graph convolution network (GCN) to learn gene feature representations from the network.
  • Utilizing a 1D convolution module for feature dimensionality adjustment.
  • Employing logistic regression with learned and original gene features for driver gene prediction.

Main Results:

  • GM-GCN demonstrated superior performance in predicting cancer driver genes compared to state-of-the-art methods.
  • The model achieved high accuracy, as indicated by the area under the receiver operating characteristic curve and the area under the precision-recall curve.
  • The approach proved effective for both pan-cancer and individual cancer type predictions.

Conclusions:

  • The proposed GM-GCN model effectively identifies cancer driver genes by incorporating gene-miRNA interactions.
  • This method offers a significant advancement over existing network-based approaches that do not consider miRNA regulation.
  • GM-GCN provides a valuable tool for cancer research, potentially aiding in the development of new diagnostic and therapeutic strategies.